First Washington Corp’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.82M Hold
106,482
0.91% 39
2025
Q1
$2.57M Buy
106,482
+47,365
+80% +$1.14M 0.9% 42
2024
Q4
$2.38M Hold
59,117
0.84% 40
2024
Q3
$3.74M Buy
59,117
+19,427
+49% +$1.23M 1.49% 29
2024
Q2
$2.1M Buy
39,690
+30,152
+316% +$1.6M 0.78% 42
2024
Q1
$782K Sell
9,538
-229,772
-96% -$18.8M 0.3% 52
2023
Q4
$4.45M Buy
+239,310
New +$4.45M 1.71% 23